Evozyne, Inc. — Form D
Evozyne, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-22. The offering totals $59.2M, of which $54.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-04-22
- Form: D
- Accession: 0001811288-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $59.2M
- Amount sold: $54.2M
- Remaining: $5.0M
- Investors: 12
- Date of first sale: 2021-04-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-396695
Issuer
- Name: Evozyne, Inc.
- CIK: 0001811288
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 330 N. WABASH AVENUE, CHICAGO, IL, 60611
- Phone: 312-847-1322
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Darien J Parhad | Executive Officer | Chicago, IL |
| Patrick J Morris | Director | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Jeffrey S Aronin | Director | Chicago, IL |
| Jeffrey S Aronin | Executive Officer | Chicago, IL |
| Antonio S Gracias | Director | Chicago, IL |
| Darien S Parhad | Executive Officer | Chicago, IL |
| Jude M Sullivan | Executive Officer | Chicago, IL |
| Aleina M Lee | Executive Officer | Chicago, IL |
| Mike S Gamson | Director | Chicago, IL |
| Mike S Gamson | Executive Officer | Chicago, IL |
| Matthew M Rizzo | Director | Chicago, IL |
| Arjun S Rallapalli | Executive Officer | Chicago, IL |
| Aris J Theologis | Director | Chicago, IL |
| Aris J Theologis | Executive Officer | Chicago, IL |
| Rama J Ranganathan | Director | Chicago, IL |
| Rama J Ranganathan | Executive Officer | Chicago, IL |
| Antonio J Gracias | Director | Chicago, IL |
Other filings by this issuer (2)
More